Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands
|
Total |
Common Stock and Capital in Excess of Par Value, Shares |
Common Stock and Capital in Excess of Par Value, Amount |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Total KLA Stockholders’ Equity |
Non-Controlling Interest |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Balance as of July 1, 2018 |
|
|
$ 617,999 |
|
|
|
|
Balance (in shares) at Jun. 30, 2018 |
|
156,048 |
|
|
|
|
|
Balance at Jun. 30, 2018 |
$ 1,620,511 |
|
617,999 |
$ 1,056,445 |
$ (53,933) |
$ 1,620,511 |
$ 0. |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Reclassification of stranded tax effects |
|
|
|
10,920 |
(10,920) |
|
|
Balance (in shares) at Jun. 30, 2018 |
|
156,048 |
|
|
|
|
|
Balance at Jun. 30, 2018 |
1,620,511 |
|
617,999 |
1,056,445 |
(53,933) |
1,620,511 |
0 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
395,944 |
|
|
395,944 |
|
395,944 |
|
Other comprehensive income (loss) |
8,611 |
|
|
|
8,611 |
8,611 |
|
Net issuance under employee stock plans(in shares) |
|
332 |
|
|
|
|
|
Net issuance under employee stock plans |
(26,961) |
|
(26,961) |
|
|
(26,961) |
|
Repurchase of common stock (in shares) |
|
(2,781) |
|
|
|
|
|
Repurchase of common stock |
(307,787) |
|
(11,010) |
(296,777) |
|
(307,787) |
|
Cash dividends and dividend equivalents declared |
(117,947) |
|
|
(117,947) |
|
(117,947) |
|
Stock-based compensation expense |
16,138 |
|
16,138 |
|
|
16,138 |
|
Balance (in shares) at Sep. 30, 2018 |
|
153,599 |
|
|
|
|
|
Balance at Sep. 30, 2018 |
1,567,369 |
|
596,166 |
1,027,370 |
(56,167) |
1,567,369 |
0 |
Balance (in shares) at Jun. 30, 2018 |
|
156,048 |
|
|
|
|
|
Balance at Jun. 30, 2018 |
1,620,511 |
|
617,999 |
1,056,445 |
(53,933) |
1,620,511 |
0 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
957,772 |
|
|
|
|
|
|
Other comprehensive income (loss) |
(4,129) |
|
|
|
|
|
|
Net loss attributable to non-controlling interest |
(83) |
|
|
|
|
|
|
Repurchase of common stock (in shares) |
|
(7,107) |
|
|
|
|
|
Repurchase of common stock |
(756,204) |
|
|
|
|
|
|
Balance (in shares) at Mar. 31, 2019 |
|
161,912 |
|
|
|
|
|
Balance at Mar. 31, 2019 |
2,885,588 |
|
1,989,914 |
928,086 |
(68,907) |
2849093年 |
36,495 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Adoption of ASC 606 | Accounting Standards Update 2014-09 |
(21,140) |
|
|
(21,215) |
75. |
(21,140) |
|
Balance as of July 1, 2018 |
1,599,371 |
|
|
1,046,150 |
(64,778) |
1,599,371 |
0 |
Balance (in shares) at Sep. 30, 2018 |
|
153,599 |
|
|
|
|
|
Balance at Sep. 30, 2018 |
1,567,369 |
|
596,166 |
1,027,370 |
(56,167) |
1,567,369 |
0 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
369,100 |
|
|
369,100 |
|
369,100 |
|
Other comprehensive income (loss) |
(14,280) |
|
|
|
(14,280) |
(14,280) |
|
Net issuance under employee stock plans(in shares) |
|
321 |
|
|
|
|
|
Net issuance under employee stock plans |
17,323 |
|
17,323 |
|
|
17,323 |
|
Repurchase of common stock (in shares) |
|
(2,556) |
|
|
|
|
|
Repurchase of common stock |
(242,401) |
|
(9,919) |
(232,482) |
|
(242,401) |
|
Cash dividends and dividend equivalents declared |
(115,184) |
|
|
(115,184) |
|
(115,184) |
|
Stock-based compensation expense |
15,695 |
|
15,695 |
|
|
15,695 |
|
Balance (in shares) at Dec. 31, 2018 |
|
151,364 |
|
|
|
|
|
Balance at Dec. 31, 2018 |
1,597,622 |
|
619,265 |
1,048,804 |
(70,447) |
1,597,622 |
0 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
192,728 |
|
|
192,728 |
|
192,728 |
|
Other comprehensive income (loss) |
1,540 |
|
|
|
1,540 |
1,540 |
|
Net loss attributable to non-controlling interest |
(83) |
|
|
|
|
|
(83) |
Assumption of stock-based compensation plan awards in connection with the acquisition of Orbotech |
13,281 |
|
13,281 |
|
|
13,281 |
|
Common stock issued upon the acquisition of Orbotech (in shares) |
|
12,292 |
|
|
|
|
|
Common stock issued upon the acquisition of Orbotech |
1,330,786 |
|
1,330,786 |
|
|
1,330,786 |
|
Net issuance under employee stock plans(in shares) |
|
26 |
|
|
|
|
|
Net issuance under employee stock plans |
(371) |
|
(371) |
|
|
(371) |
|
Repurchase of common stock (in shares) |
|
(1,770) |
|
|
|
|
|
Repurchase of common stock |
(206,017) |
|
(7,240) |
(198,777) |
|
(206,017) |
|
Cash dividends and dividend equivalents declared |
(114,669) |
|
|
(114,669) |
|
(114,669) |
|
Non-controlling interest in connection with the acquisition of Orbotech |
36,578 |
|
|
|
|
|
36,578 |
Stock-based compensation expense |
34,193 |
|
34,193 |
|
|
34,193 |
|
Balance (in shares) at Mar. 31, 2019 |
|
161,912 |
|
|
|
|
|
Balance at Mar. 31, 2019 |
2,885,588 |
|
1,989,914 |
928,086 |
(68,907) |
2849093年 |
36,495 |
Balance (in shares) at Jun. 30, 2019 |
|
159,475 |
|
|
|
|
|
Balance at Jun. 30, 2019 |
2,677,693 |
|
2,017,312 |
714,825 |
(73,029) |
2,659,108 |
18,585 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
346,525 |
|
|
346,525 |
|
346,525 |
|
Other comprehensive income (loss) |
1,174 |
|
|
|
1,174 |
1,174 |
|
Net loss attributable to non-controlling interest |
(129) |
|
|
|
|
|
(129) |
Net issuance under employee stock plans(in shares) |
|
281. |
|
|
|
|
|
Net issuance under employee stock plans |
(23,423) |
|
(23,423) |
|
|
(23,423) |
|
Repurchase of common stock (in shares) |
|
(1,659) |
|
|
|
|
|
Repurchase of common stock |
(228,496) |
|
(20,988) |
(207,508) |
|
(228,496) |
|
Cash dividends and dividend equivalents declared |
(120,669) |
|
|
(120,669) |
|
(120,669) |
|
Stock-based compensation expense |
26,944 |
|
26,944 |
|
|
26,944 |
|
Balance (in shares) at Sep. 30, 2019 |
|
158,097 |
|
|
|
|
|
Balance at Sep. 30, 2019 |
2,679,619 |
|
1,999,845 |
733,173 |
(71,855) |
2,661,163 |
18,456 |
Balance (in shares) at Jun. 30, 2019 |
|
159,475 |
|
|
|
|
|
Balance at Jun. 30, 2019 |
2,677,693 |
|
2,017,312 |
714,825 |
(73,029) |
2,659,108 |
18,585 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
805,532 |
|
|
|
|
|
|
Other comprehensive income (loss) |
(15,265) |
|
|
|
|
|
|
Net loss attributable to non-controlling interest |
(822) |
|
|
|
|
|
|
Repurchase of common stock (in shares) |
|
(5,326) |
|
|
|
|
|
Repurchase of common stock |
(821,084) |
|
|
|
|
|
|
Balance (in shares) at Mar. 31, 2020 |
|
155,049 |
|
|
|
|
|
Balance at Mar. 31, 2020 |
2,325,196 |
|
2,019,071 |
376,656 |
(88,294) |
2,307,433 |
17,763 |
Balance (in shares) at Sep. 30, 2019 |
|
158,097 |
|
|
|
|
|
Balance at Sep. 30, 2019 |
2,679,619 |
|
1,999,845 |
733,173 |
(71,855) |
2,661,163 |
18,456 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
380,555 |
|
|
380,555 |
|
380,555 |
|
Other comprehensive income (loss) |
5,097 |
|
|
|
5,097 |
5,097 |
|
Net loss attributable to non-controlling interest |
(250) |
|
|
|
|
|
(250) |
Net issuance under employee stock plans(in shares) |
|
442 |
|
|
|
|
|
Net issuance under employee stock plans |
12,262 |
|
12,262 |
|
|
12,262 |
|
Repurchase of common stock (in shares) |
|
(1,690) |
|
|
|
|
|
Repurchase of common stock |
(280,593) |
|
(21,375) |
(259,218) |
|
(280,593) |
|
Cash dividends and dividend equivalents declared |
(135,509) |
|
|
(135,509) |
|
(135,509) |
|
Stock-based compensation expense |
26,789 |
|
26,789 |
|
|
26,789 |
|
Balance (in shares) at Dec. 31, 2019 |
|
156,849 |
|
|
|
|
|
Balance at Dec. 31, 2019 |
2,687,970 |
|
2,017,521 |
719,001 |
(66,758) |
2,669,764 |
18,206 |
Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
Net income attributable to KLA |
78,452 |
|
|
78,452 |
|
78,452 |
|
Other comprehensive income (loss) |
(21,536) |
|
|
|
(21,536) |
(21,536) |
|
Net loss attributable to non-controlling interest |
(443) |
|
|
|
|
|
(443) |
Net issuance under employee stock plans(in shares) |
|
177. |
|
|
|
|
|
Net issuance under employee stock plans |
(4,284) |
|
(4,284) |
|
|
(4,284) |
|
Repurchase of common stock (in shares) |
|
(1,977) |
|
|
|
|
|
Repurchase of common stock |
(311,995) |
|
(25,436) |
(286,559) |
|
(311,995) |
|
Cash dividends and dividend equivalents declared |
(134,238) |
|
|
(134,238) |
|
(134,238) |
|
Stock-based compensation expense |
31,270 |
|
31,270 |
|
|
31,270 |
|
Balance (in shares) at Mar. 31, 2020 |
|
155,049 |
|
|
|
|
|
Balance at Mar. 31, 2020 |
$ 2,325,196 |
|
$ 2,019,071 |
$ 376,656 |
$ (88,294) |
$ 2,307,433 |
$ 17,763 |